Normally, immune checkpoints such as PD-1 and CTLA-4 pathways downregulate T cell responses to control the immune system and thus protect the body from possibly damaging responses, tumor cells can use this system to avoid immune cells’ attack through the activation of immune checkpoints and inhibition of the T cell responses (3, 4). This evidence concerns the gene PDCD1 and neoplasm.